symbol,statement_type,period_end,line_item,value
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Treasury Shares Number,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Ordinary Shares Number,124912099.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Share Issued,124912099.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Debt,474200000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Tangible Book Value,37437700000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Invested Capital,37928800000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Working Capital,18469300000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Net Tangible Assets,37437700000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Capital Lease Obligations,448300000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Common Stock Equity,37902900000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Capitalization,37902900000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Equity Gross Minority Interest,37902900000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Minority Interest,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Stockholders Equity,37902900000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Equity Interest,37652200000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Retained Earnings,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Additional Paid In Capital,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Capital Stock,250700000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Common Stock,250700000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Liabilities Net Minority Interest,12246600000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,2285600000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Non Current Liabilities,20000000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Tradeand Other Payables Non Current,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Non Current Deferred Revenue,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Non Current Deferred Taxes Liabilities,1105200000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,347200000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Long Term Capital Lease Obligation,347200000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Long Term Debt,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Long Term Provisions,802700000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Current Liabilities,9961000000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Current Liabilities,911200000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Current Deferred Taxes Liabilities,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Current Debt And Capital Lease Obligation,127000000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Current Capital Lease Obligation,101100000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Current Debt,25900000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Current Provisions,233500000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Payables,4947300000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Payable,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Dividends Payable,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Tax Payable,405300000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Accounts Payable,4542000000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Assets,50149500000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Non Current Assets,21719200000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Non Current Assets,127100000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Non Current Prepaid Assets,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Non Current Deferred Taxes Assets,1864300000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Investmentin Financial Assets,344900000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Available For Sale Securities,344900000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Trading Securities,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Long Term Equity Investment,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Investmentsin Joint Venturesat Cost,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Investment Properties,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Goodwill And Other Intangible Assets,465200000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Intangible Assets,465200000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Net PPE,18917700000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Accumulated Depreciation,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Gross PPE,18917700000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Construction In Progress,1762700000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Properties,17155000000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Machinery Furniture Equipment,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Buildings And Improvements,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Land And Improvements,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Properties,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Current Assets,28430300000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Current Assets,1233000000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Hedging Assets Current,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Assets Held For Sale Current,133300000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Restricted Cash,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Prepaid Assets,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Inventory,9038500000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Inventories,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Finished Goods,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Work In Process,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Raw Materials,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Receivables,25400000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Taxes Receivable,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Accounts Receivable,11827400000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Gross Accounts Receivable,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,6172700000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Short Term Investments,4421500000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Cash And Cash Equivalents,1751200000.0
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Cash Equivalents,
AJANTPHARM.NS,balance_sheet,2025-03-31 00:00:00,Cash Financial,
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Treasury Shares Number,
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Ordinary Shares Number,125915655.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Share Issued,125915655.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Debt,352800000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Tangible Book Value,35525300000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Invested Capital,35686800000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Working Capital,18351600000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Net Tangible Assets,35525300000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Capital Lease Obligations,337900000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Common Stock Equity,35671900000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Capitalization,35671900000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Equity Gross Minority Interest,35671900000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Minority Interest,0.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Stockholders Equity,35671900000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Equity Interest,56500000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Retained Earnings,33143500000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Additional Paid In Capital,4400000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Capital Stock,252700000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Common Stock,252700000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Liabilities Net Minority Interest,10712000000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,1754400000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Non Current Liabilities,1700000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,395400000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Tradeand Other Payables Non Current,13700000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Non Current Deferred Revenue,23400000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Non Current Deferred Taxes Liabilities,1085000000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,235200000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Long Term Capital Lease Obligation,235200000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Long Term Debt,0.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Long Term Provisions,395400000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Current Liabilities,8957600000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Current Liabilities,597300000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Current Deferred Taxes Liabilities,447700000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Current Debt And Capital Lease Obligation,117600000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Current Capital Lease Obligation,102700000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Current Debt,14900000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,177600000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Current Provisions,2232700000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Payables,5564800000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Payable,925600000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Dividends Payable,7200000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Tax Payable,447700000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Accounts Payable,4632000000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Assets,46383900000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Non Current Assets,19074700000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Non Current Assets,94400000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Non Current Prepaid Assets,128700000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Non Current Deferred Taxes Assets,1344500000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Investmentin Financial Assets,227400000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Available For Sale Securities,41600000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,185800000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Trading Securities,
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Long Term Equity Investment,0.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Investmentsin Joint Venturesat Cost,0.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Investment Properties,
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Goodwill And Other Intangible Assets,146600000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Intangible Assets,146600000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Net PPE,17209800000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Accumulated Depreciation,-8810400000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Gross PPE,26020200000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Construction In Progress,2564500000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Properties,14645300000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Machinery Furniture Equipment,14692100000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Buildings And Improvements,6649300000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Land And Improvements,2114300000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Properties,0.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Current Assets,27309200000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Current Assets,1330700000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Hedging Assets Current,124800000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Assets Held For Sale Current,88500000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Restricted Cash,12800000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Prepaid Assets,959300000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Inventory,8283600000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Inventories,547100000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Finished Goods,4860500000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Work In Process,543500000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Raw Materials,2332500000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Receivables,233400000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Taxes Receivable,543000000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Accounts Receivable,12468400000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-88300000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Gross Accounts Receivable,12556700000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,4595400000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Short Term Investments,3300500000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Cash And Cash Equivalents,1294900000.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Cash Equivalents,0.0
AJANTPHARM.NS,balance_sheet,2024-03-31 00:00:00,Cash Financial,1294900000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Treasury Shares Number,
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Ordinary Shares Number,126681155.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Share Issued,126681155.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Debt,356300000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Tangible Book Value,33802400000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Invested Capital,33894200000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Working Capital,16947200000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Net Tangible Assets,33802400000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Capital Lease Obligations,342000000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Common Stock Equity,33879900000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Capitalization,33892400000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Equity Gross Minority Interest,33879900000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Minority Interest,0.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Stockholders Equity,33879900000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Equity Interest,3400000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Retained Earnings,31412700000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Additional Paid In Capital,4400000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Capital Stock,252700000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Common Stock,252700000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Liabilities Net Minority Interest,12910300000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,1517500000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Non Current Liabilities,26700000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,241500000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Tradeand Other Payables Non Current,10100000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Non Current Deferred Revenue,26700000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Non Current Deferred Taxes Liabilities,977200000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,262000000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Long Term Capital Lease Obligation,249500000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Long Term Debt,12500000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Long Term Provisions,241500000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Current Liabilities,11392800000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Current Liabilities,231500000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Current Deferred Taxes Liabilities,330700000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Current Debt And Capital Lease Obligation,94300000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Current Capital Lease Obligation,92500000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Current Debt,1800000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,140200000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Current Provisions,1864300000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Payables,4750600000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Payable,514700000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Dividends Payable,8200000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Tax Payable,330700000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Accounts Payable,4227700000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Assets,46790200000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Non Current Assets,18450200000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Non Current Assets,53200000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Non Current Prepaid Assets,110100000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Non Current Deferred Taxes Assets,967700000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Investmentin Financial Assets,290000000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Available For Sale Securities,39000000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,251000000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Trading Securities,
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Long Term Equity Investment,0.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Investmentsin Joint Venturesat Cost,0.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Investment Properties,0.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Goodwill And Other Intangible Assets,77500000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Intangible Assets,77500000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Net PPE,16981600000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Accumulated Depreciation,-7622500000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Gross PPE,24604100000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Construction In Progress,2094700000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Properties,14886900000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Machinery Furniture Equipment,13879200000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Buildings And Improvements,6427700000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Land And Improvements,2202500000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Properties,0.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Current Assets,28340000000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Current Assets,916100000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Hedging Assets Current,0.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Assets Held For Sale Current,88200000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Restricted Cash,10700000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Prepaid Assets,586300000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Inventory,8156300000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Inventories,517100000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Finished Goods,4470600000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Work In Process,524600000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Raw Materials,2644000000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Receivables,125800000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Taxes Receivable,402700000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Accounts Receivable,10569000000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-110400000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Gross Accounts Receivable,10679400000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,8401000000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Short Term Investments,5102700000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Cash And Cash Equivalents,3298300000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Cash Equivalents,465000000.0
AJANTPHARM.NS,balance_sheet,2023-03-31 00:00:00,Cash Financial,2833300000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Treasury Shares Number,4200000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Ordinary Shares Number,128123655.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Share Issued,128123655.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Debt,250300000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Tangible Book Value,32553300000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Invested Capital,32662600000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Working Capital,16170700000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Net Tangible Assets,32553300000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Capital Lease Obligations,231200000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Common Stock Equity,32643500000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Capitalization,32659900000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Equity Gross Minority Interest,32643500000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Minority Interest,
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Stockholders Equity,32643500000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Equity Interest,3000000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Retained Earnings,27177000000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Additional Paid In Capital,26300000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Capital Stock,171700000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Common Stock,171700000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Liabilities Net Minority Interest,7912300000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,1438400000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Non Current Liabilities,-100000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,193200000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Tradeand Other Payables Non Current,10900000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Non Current Deferred Revenue,30000000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Non Current Deferred Taxes Liabilities,1018700000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,185700000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Long Term Capital Lease Obligation,169300000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Long Term Debt,16400000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Long Term Provisions,193200000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Current Liabilities,6473900000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Current Liabilities,644100000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Current Deferred Taxes Liabilities,79400000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Current Debt And Capital Lease Obligation,64600000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Current Capital Lease Obligation,61900000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Current Debt,2700000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,108100000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Current Provisions,108100000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Payables,3969200000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Payable,688400000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Dividends Payable,9100000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Tax Payable,79400000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Accounts Payable,3271700000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Assets,40555800000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Non Current Assets,17911200000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Non Current Assets,65400000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Non Current Prepaid Assets,118800000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Non Current Deferred Taxes Assets,555500000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Investmentin Financial Assets,294200000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Available For Sale Securities,43200000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,251000000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Trading Securities,
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Long Term Equity Investment,0.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Investmentsin Joint Venturesat Cost,0.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Investment Properties,84100000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Goodwill And Other Intangible Assets,90200000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Intangible Assets,90200000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Net PPE,16474200000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Accumulated Depreciation,-6834200000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Gross PPE,23308400000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Construction In Progress,1528600000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Properties,14945600000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Machinery Furniture Equipment,13275500000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Buildings And Improvements,6303400000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Land And Improvements,2200900000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Properties,0.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Current Assets,22644600000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Current Assets,200000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Hedging Assets Current,171000000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Assets Held For Sale Current,0.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Restricted Cash,54200000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Prepaid Assets,437900000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Inventory,7910700000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Inventories,494100000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Finished Goods,4551100000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Work In Process,465000000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Raw Materials,2400500000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Receivables,150900000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Taxes Receivable,439400000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Accounts Receivable,10198100000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-147400000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Gross Accounts Receivable,10345500000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,3282200000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Short Term Investments,1218600000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Cash And Cash Equivalents,2063600000.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Cash Equivalents,0.0
AJANTPHARM.NS,balance_sheet,2022-03-31 00:00:00,Cash Financial,2063600000.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Treasury Shares Number,735000.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Ordinary Shares Number,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Share Issued,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Debt,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Tangible Book Value,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Invested Capital,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Working Capital,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Net Tangible Assets,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Capital Lease Obligations,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Common Stock Equity,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Capitalization,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Equity Gross Minority Interest,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Minority Interest,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Stockholders Equity,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Equity Interest,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Retained Earnings,21557300000.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Additional Paid In Capital,24000000.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Capital Stock,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Common Stock,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Liabilities Net Minority Interest,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Non Current Liabilities,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,179300000.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Tradeand Other Payables Non Current,12500000.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Non Current Deferred Revenue,33400000.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Non Current Deferred Taxes Liabilities,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Long Term Capital Lease Obligation,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Long Term Debt,16000000.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Long Term Provisions,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Current Liabilities,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Current Liabilities,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Current Deferred Taxes Liabilities,489200000.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Current Debt And Capital Lease Obligation,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Current Capital Lease Obligation,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Current Debt,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,117100000.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Current Provisions,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Payables,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Payable,638100000.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Dividends Payable,8100000.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Tax Payable,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Accounts Payable,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Assets,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Non Current Assets,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Non Current Assets,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Non Current Prepaid Assets,126400000.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Non Current Deferred Taxes Assets,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Investmentin Financial Assets,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Available For Sale Securities,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Trading Securities,0.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Long Term Equity Investment,0.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Investmentsin Joint Venturesat Cost,0.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Investment Properties,89000000.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Goodwill And Other Intangible Assets,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Intangible Assets,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Net PPE,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Accumulated Depreciation,-5817500000.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Gross PPE,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Construction In Progress,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Properties,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Machinery Furniture Equipment,12614100000.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Buildings And Improvements,6065800000.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Land And Improvements,2351800000.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Properties,0.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Current Assets,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Current Assets,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Hedging Assets Current,40900000.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Assets Held For Sale Current,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Restricted Cash,71000000.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Prepaid Assets,414000000.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Inventory,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Inventories,580800000.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Finished Goods,3691600000.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Work In Process,480000000.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Raw Materials,2912300000.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Receivables,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Taxes Receivable,521000000.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Accounts Receivable,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-135700000.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Gross Accounts Receivable,7520000000.0
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Short Term Investments,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Cash And Cash Equivalents,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Cash Equivalents,
AJANTPHARM.NS,balance_sheet,2021-03-31 00:00:00,Cash Financial,1775100000.0
